论文部分内容阅读
1993年是我国探索在市场经济条件下改革和发展的一年。国家采取了加强宏观调控举措,整个国民经济取得了较快发展。医药市场社会需求持续稳定增长,由于深层次的改革尚未配套,多方插手医药批发经营有增无减,市场秩序继续混乱,不正之风盛行,国有医药商业企业受三角债务困挠,资金严重缺乏,购销增幅急转直下,负增长面继续扩大。据中国医药商业协会讯报导,1993年全国四大类医药商品全年购进总额为194.66亿元,比上年增长8.34%,对照去年同比增幅11.66%,下降3.34个百分点;全年销售总额267.95亿元,比上年增长9.81%,对照上年同
The year 1993 was a year for China to explore reform and development under the conditions of a market economy. The country has taken measures to strengthen macro-control, and the entire national economy has achieved rapid development. The social demand in the pharmaceutical market continued to grow steadily. As deep-seated reforms have not yet been completed, multi-pronged pharmaceutical wholesale operations have increased unabated, market orders continue to be turbulent, and unhealthy tendencies have prevailed. State-owned pharmaceutical commercial enterprises have been plagued by triangular debt and the funds have been seriously deficient. The increase in purchase and sales turned sharply, and the negative growth continued to expand. According to a report from the China Pharmaceutical Business Association, total purchases of four major categories of Chinese medicines in the year were 19.866 billion yuan in 1993, an increase of 8.34% from the previous year, an increase of 11.66% year-on-year, which was a decrease of 3.34 percentage points; annual sales were 267.95 Billion yuan, an increase of 9.81% over the previous year, compared with the previous year